__NUXT_JSONP__("/drugs/HER2_Inhibitor_CP-724714", (function(a,b,c,d){return {data:[{drug:{slug:b,emaEpar:[],fdaDrugLabel:[],id:b,nciThesaurus:{casRegistry:a,chebiId:a,chemicalFormula:a,definition:"An orally bioavailable quinazoline with potential antineoplastic activity.  CP-724,714 selectively binds to the intracellular domain of HER2, reversibly inhibiting its tyrosine kinase activity and resulting in suppression of tumor cell growth.  HER2, a member of the epidermal growth factor receptor (EGFR) family, is overexpressed in many adenocarcinomas, particularly breast cancers.",fdaUniiCode:"I05QZ0S4V3",identifier:"C26648",preferredName:c,semanticType:"Pharmacologic Substance",subclassOf:["C159156"],synonyms:["CP 724714","CP-724,714","CP-724-714","CP-724714","CP724714",c]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FHER2_Inhibitor_CP-724714",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("","HER2_Inhibitor_CP-724714","HER2 Inhibitor CP-724,714","2021-10-30T13:38:08.463Z")));